3 September 2012 The South African government’s programme to prevent mother-to-child transmission of HIV has helped save the lives of more than a hundred thousand babies, Health Minister Aaron Motsoaledi told Parliament in Cape Town last week. According to figures from the Medical Research Council, the transmission rate from mother to child decreased from 8% in 2008 to 2.7% last year. With over 1.7-million South Africans now on antiretroviral (ARV) treatment, Motsoaledi said the country was beginning to see an increase in life expectancy – with researchers in rural KwaZulu-Natal having found a six-year increase in life expectancy with those on ARVs, for example.‘Getting closer to target of curing tuberculosis’ Motsoaledi added that the rate at which tuberculosis was being cured in South Africa was slowly going up and now stood at 73%. “If we add those that have completed their treatment, but where we don’t yet have their last sputum test, then the national figure standards at 79% for 2011,” Motsoaledi said. “While this is still short of the national target of 85%, we are getting closer each year to this target.” Motsoaledi also detailed a number of steps his department was taking to increase the number of doctors and nurses needed to implement the National Health Insurance (NHI) scheme. The average number of matriculants sent by the department to study medicine in Cuba was increased from 60 a year to 80 last year, and would this year be increased to 1 000, he said.Increasing the intake of medical students The Health department had also been encouraging the country’s eight medical schools to increase their intake of medical students – with the University of the Witwatersrand having last year accepted 40 extra students, which the department covered with an additional R8-million. The other universities followed this year and increased their intake by an overall total of 160 students, for which the department provided R48-million. He said the department also plans to set up a new medical school in Limpopo province and to build a new tertiary hospital in Mpumalanga in anticipation of the new university planned to be set up there by 2014. The department would also rebuild the other medical schools with their central hospitals, including: George Mukhari Central Hospital in Medunsa, Chris Hani Baragwanath Hospital under Wits University, King Edward VIII Hospital under the Nelson Mandela School of Medicine (University of KwaZulu-Natal) and the Walter Sisulu School of Medicine in Mthatha in the Eastern Cape province. Lastly, a total of R1.2-billion would be spent by the department over the next three years to refurbish and re-equip 122 nursing colleges around the country. Source: SANews.gov.za
Cognitive Automation is the Immediate Future of… Related Posts Massive Non-Desk Workforce is an Opportunity fo… michael tchong Living In AmericaThat producing a product as complex as a car with its myriad of alloys and steel and hundreds of technology features is not a trivial procedure is underscored by this Esquire article, How to Build an American Car, which breathtakingly describes the production process.So would Apple benefit from building the iPhone in America? There are two trends to consider here. First, it’s increasingly likely that volatility in the oil business will cause fuel prices to double in the not-too-distant future. That will make shipping even a high-value iPhone from China via FedEx a less attractive proposition.Another is that increasingly the added value in any consumer product is software. And in this area, America still out-shines the rest of the world although domestic educational obstacles and the ascent of India may diminish that advantage.Still though, I’m happy to see that once-considered-dead General Motors can not only match global competitors in engineering but also reinvent an area where automobiles will increasingly have to shine – the human-machine interface. Don’t believe me? I have just one word to say, iDrive.Happy motoring America, and please contribute software innovations for the automobile and computer revolution to our Spigit innovation crowdsourcing engine. IT + Project Management: A Love Affair Tags:#Digital Lifestyle#enterprise#Internet of Things#NYT#Trends In January, The New York Times wondered aloud why Apple did not make the iPhone in America. The story heaped a torrent of commentary and scrutiny on Silicon Valley’s most valuable company. Whether you think manufacturing in the U.S. is right or not for Apple, Cadillac is proving that American-made technology can compete with the best.The new Cadillac ATS was designed to be a luxury car world-beater – a tall order that required catching up to the likes of BMW’s 3-series and Mercedes’ C-class. But the folks at General Motors took a unique approach to the job and the ATS definitely arrives at the head of its class.What Cadillac did is often overlooked in Silicon Valley. To help design the Cadillac User Experience (CUE), the company assembled a team of designers, engineers and software developers to shadow drivers while observing them in their natural habitat.This “contextual design” technique required team members to accompany actual consumers, an eye-opening experience. The shadow team was able to identify several different driving styles, which were categorized under a pseudonym. One type of driver, dubbed “Spencer,” always needed to check text messages immediately, while ‘‘Emily” liked listening to music, whether on her phone, iPod or flash drive.Cadillac spokesperson David Caldwell tells me, “We took a hard look at what carmakers call ‘infotainment.’ Everyone’s doing that, that’s sort of par for the course. We took a bit of a riskier approach: Is there something we can do that says ‘hey these guys are doing something different?’”Enter A New GUIWhat became clear quickly is that most drivers are distracted by a myriad of bells, beeps and whistles emitted by our digital lifestyle tools. So Cadillac engineers set out to develop a less invasive type of user interface, one that communicates via seat vibrations.You might call it “BUI,” but GM prefers the less colloquial Cadillac Safety Alert Seat. The Alert Seat is able to tell a driver whether an object is nearby on the left by triggering a pulse on the left side of the seat.Cadillac also joins another innovative force in technology: the open source movement. The CUE system runs on a triple-core ARM 11 processor and uses a Linux platform so developers can help keep the architecture fresh with new extensions.CUE powers both an 8-inch capacitive touch screen, reportedly the first non-resistive display in an automobile, and a second, 12.3-inch fully configurable instrument cluster mounted behind the steering wheel.Another automotive engineering feat was the addition of haptic feedback. There’s a proximity sensor, which brightens the display when a driver’s hand approaches the system’s user interface and a touch screen that provides both pulse feedback and the ability to swipe and pinch. 3 Areas of Your Business that Need Tech Now
This year’s mandatory across-the-board budget cuts to U.S. research agencies have translated into less money for academic scientists and delays in their research projects.A survey of public and private U.S. research universities released today finds that 70% of the 74 respondents report that sequestration has caused a reduction in federal research grants to their institutions and has slowed campus-based research. The biggest effects are fewer student positions (31%), a reduction in temporary or part-time staff positions (30%), and a decline in postdoctoral fellows (24%). Some 22% of respondents said they also have had to reduce the number of permanent staff members.The survey, conducted last month, polled 171 members of the Association of American Universities and the Association of Public and Land-grant Universities. “The survey shows that sequestration is already eroding America’s research capabilities at universities across the country,” according to a statement issued by the two organizations and by The Science Coalition, which lobbies for academic research.Sign up for our daily newsletterGet more great content like this delivered right to you!Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of theCook IslandsCosta RicaCote D’IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People’s Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexicoMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalestinianPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarReunionRomaniaRussian FederationRWANDASaint Barthélemy Saint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweI also wish to receive emails from AAAS/Science and Science advertisers, including information on products, services and special offers which may include but are not limited to news, careers information & upcoming events.Required fields are included by an asterisk(*)
On 2 September, a 39-year-old woman in Bethesda, Maryland, received a novel Ebola vaccine never given to humans before. In as little as 2 months, this same vaccine may go into the arms of thousands of health care workers and other first-line responders to the Ebola epidemic now wreaking havoc in West Africa. No experimental vaccine has ever been on a faster track toward widespread use. “It’s absolutely unprecedented,” said Marie-Paule Kieny, an assistant director-general at the World Health Organization (WHO).On 5 September, more than 200 “technical experts” convened by WHO recommended bypassing the usual time-consuming regulatory pathways for potential Ebola vaccines and therapies. “We have to change the sense that there is no hope in this situation to a realistic hope,” Kieny said. No one expects a vaccine will slow the epidemic directly, yet it could help keep and attract workers leading containment efforts.The Bethesda woman is taking part in a phase I trial at the U.S. National Institutes of Health (NIH), one of several small studies getting under way in four countries to assess this vaccine’s safety and the immune responses it triggers. The genetically engineered vaccine she received contains genes for a surface protein from two different strains of Ebola stitched into a harmless chimpanzee adenovirus that serves as a vector. Pharmaceutical giant GlaxoSmithKline (GSK), which is developing the vaccine in collaboration with NIH’s National Institute of Allergy and Infectious Diseases (NIAID), may produce as many as 10,000 doses by the end of the year.Sign up for our daily newsletterGet more great content like this delivered right to you!Country *AfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, The Democratic Republic of theCook IslandsCosta RicaCote D’IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and Mcdonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People’s Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, The Former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexicoMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorwayOmanPakistanPalestinianPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarReunionRomaniaRussian FederationRWANDASaint Barthélemy Saint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweI also wish to receive emails from AAAS/Science and Science advertisers, including information on products, services and special offers which may include but are not limited to news, careers information & upcoming events.Required fields are included by an asterisk(*)A second Ebola vaccine starting human tests this month uses a similar Trojan horse strategy. Initially engineered by the Public Health Agency of Canada and now being developed by NewLink Genetics of Ames, Iowa, this vaccine contains the Ebola surface protein gene inside a weakened version of vesicular stomatitis virus (VSV), which commonly infects farm animals. Most of the 1500 doses of this vaccine that exist will be used in clinical studies, a company representative says.Both vaccines have protected monkeys and smaller animals in lab experiments. A study published online on 7 September in Nature Medicine shows that monkeys primed with the NIAID/GSK preparation and boosted by yet another vaccine that uses a vector known as MVA—a modified version of the smallpox vaccine virus—were protected from an Ebola virus “challenge” 10 months after their last vaccination. The researchers, led by NIAID’s Nancy Sullivan, claim this is the first demonstration of “durable” protection from Ebola virus.If the ongoing safety trials are encouraging—and results will be in as soon as November—health care workers and first responders would be the first to get the vaccines, following the recommendation of another WHO panel in August. Many of these responders have been killed and sickened by the virus, and recruiting people to fight the epidemic has been difficult. But putting the vaccines on such a fast track raises a host of perplexing issues “that the field has to think through very carefully,” says John Mascola, who heads NIAID’s Vaccine Research Center (VRC).Typically, vaccines that pass phase I safety trials move into expanded phase II trials meant to answer the same questions in more people, finally moving into phase IIb and phase III tests to determine whether they actually work and should go to market. Mascola and other Ebola vaccine developers have long contended that traditional efficacy trials could not be done because past outbreaks have ended quickly with the help of standard infection control procedures such as isolating confirmed cases, testing their contacts, and making sure that all health care workers wear personal protective equipment.Instead, researchers had planned to take advantage of what’s known as the Animal Rule at the U.S. Food and Drug Administration (FDA). The rule says when efficacy studies “are not ethical or feasible,” FDA will license vaccines for diseases if they work in two animal models and if large-scale phase II studies conducted in humans prove they are safe and trigger immune responses that mirror those in protected animals.But with today’s fast-moving epidemic, which has spread to five West African countries and killed more than half of the roughly 4000 cases, talk about large phase II studies in unaffected populations has gone out the window. Now, the push is to vaccinate people at high risk and try to gain interpretable data, says Adrian Hill, director of the Jenner Institute at the University of Oxford in the United Kingdom. Hill’s group will soon launch a small safety study of the NIAID/GSK vaccine, and he is confident it will pass muster. “Then it’s decision time,” he says. “Not just whether we go forward but how to go forward.”Traditionally, efficacy trials randomly assign participants to receive the vaccine or a dummy shot. That’s clearly not ethical here, so some researchers are calling for a “step-wedge” trial, which analyzes what happens to people at similar risk who receive the vaccine at different times. That way those who have been vaccinated can be compared with others who have yet to receive their shots. “You can’t give everyone the vaccine the same day,” Hill notes.But a step-wedge design could face serious limitations. The rate of spread can differ between sites because one might have, say, better or worse personal protection measures, which could cloud analyses of a vaccine’s shortcomings or strengths. Researchers might also have trouble detecting efficacy if a vaccine offers only partial protection, NIAID’s Mascola says. “If there’s a 50% mortality with Ebola and you use the vaccine and it’s 40% protective, what does that mean?” he asks.Impassioned debates also surround which experimental vaccine to deploy. As the Nature Medicine study shows, the chimp adenovirus vaccine worked best when boosted with the MVA-Ebola construct. But that’s not being assessed in the initial human trials. Mascola says a company has made the MVA preparation in bulk but it’s not ready for testing.Thomas Geisbert, a researcher at the University of Texas Medical Branch in Galveston, who helped develop several VSV Ebola vaccines, including the one made by NewLink Genetics, contends “it’s a much stronger vaccine system.” The VSV replicates, unlike the chimpanzee adenovirus vector, stimulating an immune response that Geisbert argues is as good as the one achieved by the prime-boost approach NIAID has championed. “In the context of an outbreak, where you are going to put first responders on an airplane, you don’t have time for a prime-boost,” he says. “You need a single injection.”But even though this VSV is weakened, safety concerns remain about the possibility that it could cause neurological disease, as it has in some animal studies, or infect livestock. And Anthony Fauci, who heads NIAID, says that the chimpanzee adenovirus vaccine may work well enough without the extra boost, noting that a single injection protected 100% of monkeys challenged with Ebola virus at 5 weeks. “The vaccine was developed to be able to induce immunity really fast,” he says.Fauci and his NIAID colleagues say it makes sense to test different vaccine strategies in parallel. “We’ve been fooled by trying to translate monkey findings to humans before,” says Fauci, who notes that an AIDS vaccine worked well in monkeys and actually increased HIV infection rates when tested in humans.Gary Nabel, who headed NIAID’s VRC before leaving in 2012 to join Sanofi in Cambridge, Massachusetts, says manufacturers should massively scale up production now, before trial results are in. “If it were me personally, I’d err on the side of caution, and I’d think carefully about stockpiling doses,” Nabel says. “If it isn’t safe, you throw away those lots. In the worst case you’ve wasted some money.”If the virus spreads even farther and one of these vaccines does prove safe and effective but is not available, “I think there’ll be a lot of finger-pointing,” Nabel says. “Extraordinary times call for extraordinary measures, and this is an extraordinary time.”*The Ebola Files: Given the current Ebola outbreak, unprecedented in terms of number of people killed and rapid geographic spread, Science and Science Translational Medicine have made a collection of research and news articles on the viral disease freely available to researchers and the general public.
A disappointed Sri Lanka captain Dinesh Chandimal said not playing well in the Powerplay overs cost his inexperienced side the just-concluded Twenty20 series against India.In Ranchi, the Lankan bowlers bled runs throughout while here in the final match , they lost half the side inside first six overs. “Throughout the series we played good cricket. In the first game we got momentum but in the second and third games, we did not start well. In Ranchi, we did not bowl well in the first six overs and here we lost four wickets during the Powerplay overs.”These were the mistakes in the last two games,” Chandimal said after the nine-wicket loss in the third T20 here Sunday night. (India top contenders for World T20: Dhoni )Chandimal also rued the lack of experienced players in the side to counter the Indian team.”We have got an inexperienced team. They don’t know how to stay at the crease and get some more runs. We struggled with that. I think they will learn as soon as possible and we are looking forward to do well in the next series.”The Sri Lankan captain though took out a few positives from the lost series, saying they found a players for the future.”In Dushmanta (Chameera), Dasun Shanaka, Kasun Rajitha, we found those players for future, we can get this positive out of the series,” he said.
Update: Taiwanese company HTC on Thursday launched its flagship phone of the year, the HTC 10 in India. Globally launched on April 12, the ’10’ is HTC’s answer to Samsung’s Galaxy S7 (and S7 Edge) and LG’s G5. HTC’s latest One-range phone comes sans the One (as well as the ‘M’) moniker and is simply called the HTC 10. The HTC 10 is ailing HTC’s answer to the Galaxies and the G5s of the world. After failing to make an impression with its previous flagship phone, the company will be looking to make a comeback and set cash counters ticking. About time, we say! Whether or not the HTC 10 would end up being the ticket to fame (redemption mostly) that it needs oh so badly is yet to be seen.For now, here’s everything to know about the new HTC 10, the latest and greatest phone from the Taiwanese tech giant.Design and build quality The HTC 10 has a full-metal unibody with distinct chamfers. The front boasts of Corning’s Gorilla Glass 4. Speaking of design, the HTC 10 is a mashup beteween the One A9 and the company’s One line-up of phones. It comes with front mounted fingerprint scanner and USB Type-C port for charging and data syncing. The HTC10 isn’t waterproof or dustproof.DisplayThe phone comes with a 5.2-inch QuadHD Super LCD 5 display with a 1440 x 2560 pixels resolution and 565 ppi pixel density.Also Read: HTC 10 with Snapdragon 820, 4GB RAM and BoomSound audio launched SoftwareYou get Android 6.0 Marshmallow-based Sense UI which is HTC’s custom take on Android.advertisementProcessor, RAM and storageThe HTC 10 comes in two variants: one with quad-core Qualcomm Snapdragon 820 processor with 4GB RAM and 32GB/64GB memory, and another (HTC 10 Lifestyle) variant with an octa-core Qualcomm Snapdragon 652 processor with 3GB RAM and 32GB memory. HTC 10 Lifestyle is the one that should be coming to India. There is however no confirmation from the company on this yet. Both the variants support expandable storage of up to 2TB via microSD card.Camera The HTC 10 sports a 12-megapixel (UltraPixel) camera on the rear with f/1.8 aperture, laser autofocus, Optical Image Stabilisation and dualLED flash. The rear camera further supports RAW format and 4K video recording. The phone also has a 5-megapixel camera on the front with f/1.8 aperture, autofocus, Optical Image Stabilisation and a screen flash.Audio The HTC 10 supports BoomSound Hi-Fi with Dolby Audio. It has a dual speaker layout boasting of a separate tweeter and woofer design along with a dedicated amplifier for each.Also Read: 10 features that stand out in HTC 10 Battery The phone is backed by a 3,000mAh battery which is non-removable. Fast charging is supported. Wireless charging isn’t.Additionally The HTC 10 supports Apple’s AirPlay wireless audio streaming format out-of-the-box which means it will be able to stream audio to Apple certified speakers as well as Apple TV.Pricing and availability The HTC 10 has been priced at Rs 52,990 in India. The phone will be available for buying from June 5 and the first 500 customers will receive free Ice View case with the phone.
The next iPhone, which could be iPhone 8 or iPhone 7S, will be an important one for Apple as the company marks its 10th anniversary next year. Apple had launched the first iPhone in June 2007, so the next iPhone has to be remarkable, at least on Apple’s part. One of the busiest jobs in the world is of those who keep track of iPhone rumours and leaks. It has been just two months when Apple launched iPhone 7 and iPhone 7 Plus and rumours of iPhone 8 have already started doing rounds.While compiling all the leaks and reports one gets a sense that the Cupertino giant is definitely planning something big. One thing which is a given is that it’s about time Apple made a big design change considering the last design change happened with iPhone 6 three years ago.Most of the reports regarding the iPhone 8 are in fact design changes that will also add utility to the flagship. Here is everything that has been rumoured to feature in the iPhone 8.Wireless chargingMing-Chi Kuo, a famous Apple analyst, had said earlier this year that Apple is working on a major design overhaul in 2017. The KGI analyst had said that the iPhone 8 will be an all-glass affair, now another report by Nikkei also says a similar thing.According to Nikkei, Foxconn is making wireless charging modules for Apple. However, it doesn’t suggest that if the wireless charging module will be incorporated in the iPhone 8.If Ming-Chi Kuo’s earlier comment is anything to go by, wireless charging should come with iPhone 8 only since a phone needs a glass back to support the feature. Both the rumours support each other here.advertisementAlso read: iPhone 7 and iPhone 7 Plus review: The best iPhones Apple has made Curved, OLED displaySome reports ahead of iPhone 7 had suggested that Apple is talks with display manufacturers including Samsung and LG Display for OLED displays. Now according to another Nikkei report, the president of Sharp corp., Tai Jeng-wu told students at Tatung University that Apple may switch to OLED displays soon.”The iPhone has been evolving and now it is switching from LTPS (low-temperature poly-silicon) to OLED panels,” said Tai.”We don’t know whether Apple’s OLED iPhones will be a hit, but if Apple doesn’t walk down this path and transform itself, there will be no innovation. It is a crisis but it is also an opportunity,” he added.Tai also suggested that the company may start manufacturing in the US as well if a “key customer” wants them to.”We are now building a new [OLED] facility in Japan. We can make [OLED panels] in the U.S. too,” he said. “If our key customer demands us to manufacture in the U.S., is it possible for us not to do so?” said Tai.Apple currently uses LTPS (low-temperature poly-silicon) panels in iPhones. Switching to OLED display will make iPhone display sharper and brighter. The report also suggests that Apple may try its hands on curved display with the coming iPhone.According to Nikkei, Apple will launch not two but three iPhones next year. It says that two of these phones will come with the usual LTPS display while the premium variant will sport a 5.5-inch curved OLED display.Also read: Smartphone with best camera: Apple iPhone 7 No home buttonWith the iPhone 7 and iPhone 7 Plus, Apple has already replaced the clickable home button for a capacitive touch panel with support for 3D Force Touch and haptic feedback built into it. The company may go one step ahead with the iPhone 8 by entirely removing the existence of a home button.Apple earlier had filed a patent on USPTO that reads, “A capacitive fingerprint sensor, including: a dielectric structure having a contact surface and a sensor surface; an array of capacitive sensing elements held on or near the sensor surface of the dielectric structure; and an electrostatic lens formed within the dielectric structure.”This means home button will still be there at the bottom of the display, however, it will not be clickable or physically visible. Does this mean the whole front panel will probably work as a display? Yes, it probably will.
World Wrestling Entertainment (WWE) made a one-show stop on their Live tour of the middle-east and India on December 9 for the WWE Supershow at the Indira Gandhi Indoor stadium in New Delhi.The night saw the WWE superstars duking it out for the crowd of thousands that witnessed the epic show on Indian soil, second year in a row. Jinder Mahal and Triple H met in the main event, but it was the King of kings who walked away the victor on the night.And the #KingOfKings @TripleH obliged to @JinderMahal & the @SinghBrosWWE’s request! #WWELiveIndia pic.twitter.com/1tJgY7KI22- WWE (@WWEIndia) December 9, 2017After the show down, Triple H said it was an honour to come to the country that India is in safe hands.”I have been coming here since 1996, and it is an honour to be back here again. But it is an honour to step in this ring with the Modern Day Maharaja. I can tell you this many people may criticise you, many people may hate for no reason, but know this, you have earned my respect.” Triple H said to a resounding ovation from the crowd.Triple H then proceeded to dance ‘bhangra’ with Jinder Mahal and the Singh Brothers.WWE Superstar Sasha Banks who went down to WWE RAW Women’s champion Alexa Bliss, was on tour in and around the country’s capitol, with the Singh Brothers, Titus O’Neil and Kavita Devi for company.And when it comes to Desi dance moves, @SashaBanksWWE isn’t too bad either. #WWELiveIndia pic.twitter.com/kgt8dPpha8advertisement- WWE (@WWEIndia) December 9, 2017Thank you @wweindia now its show time. #wweindia pic.twitter.com/DePobFwke3- $asha Banks (@SashaBanksWWE) December 9, 2017WWE Photo: Sasha Banks in a saree, with the Singh Brothers Bollywood star Varun Dhawan too entered the ring to enthral the crowd with Daniel Bryan’s famous ‘Yes!’ chants and Stone Cold’s ‘Hell Yeah’.Gimme a hell yeah. What an incredible crowd and brilliant matches my first time in a wwe ring thank you @WWEIndia pic.twitter.com/EPM8SzG0yi- Varun Dhawan (@Varun_dvn) December 9, 2017The Shield were easily the crowd favourites on the night, receiving the loudest cheer, as WWE Cruiserweight champion Enzo Emore and Elias drew the most heat from the audience at the Indira Gandhi Indoor stadium. The crowd also got behind the home team of Jeet Rama and Kishan Rafter.The @WWEUniverse in #India chanted ‘S-A-W-F-T’! But @real1 wasn’t too impressed! #WWELiveIndia pic.twitter.com/vrYtYPJR23- WWE (@WWEIndia) December 11, 2017He’s got the whole world in his hands…@WWEBrayWyatt #WWELiveIndia pic.twitter.com/o5ev9SkQEj- WWE (@WWEIndia) December 9, 2017Here are some memorable moments from the WWE Supershow on December 9: WWE Photo: Elias performing for the crowdWWE Photo: Bollywood star Varun DhawanWWE Photo: Finn Balor with the Balor ClubWWE Photo: Alexa Bliss with the WWE RAW Women’s Championship beltWWE Photo: Roman Reigns with the WWE Intercontinental Championship beltWWE Photo: Kalisto making his entrance
DETROIT (AP) — The Milwaukee Bucks know they are often considered a one-man team.Saturday night, they took some major steps toward changing that perception.On a night where Giannis Antetokounmpo was limited by foul trouble, the Bucks had seven players score in double figures and beat the Detroit Pistons 119-103 to take a 3-0 lead in the first-round series.“That’s something we’ve been working on all year,” Bucks coach Mike Budenholzer said. “We play together and take what the opponent gives us. It isn’t all about Giannis, as great and amazing as he is. We have a lot of guys who can make plays and Giannis knows when to step back and let them carry the load.”The Bucks can finish off the Eastern Conference series Monday night in Detroit after winning the first three games by an average of 24 points.The Bucks overcame 27 points, seven rebounds and six assists from Blake Griffin in his return from a right knee injury. He missed the first two games of the series after sitting out four of the final six in the regular season.Detroit Pistons guard Ish Smith knocks the ball away from Milwaukee Bucks forward Khris Middleton (22) during the first half of Game 3 of a first-round NBA basketball playoff series, Saturday, April 20, 2019, in Detroit. (AP Photo/Carlos Osorio)“That young man is giving us everything his body will give, and we need every bit of it,” Pistons coach Dwane Casey said. “He has a presence that no one else on our team can provide.”Griffin had an immediate defensive impact, forcing two turnovers on Milwaukee’s first three possessions, but struggled to keep up in transition.“I don’t know what percentage I’m at. I don’t really worry about things like that,” he said. “If I can play, I’m going to playAntetokounmpo had 14 points and 10 rebounds, and Khris Middleton led the Bucks with 20, Eric Bledsoe and Brook Lopez each had 19, and Lopez added seven rebounds and five blocks. Ersan Ilysaova (15), Nikola Mirotic (12) and George Hill (11) all reached double figures as part of the second unit.“They came out strong in the first quarter and then Ersan came in and hit three straight threes to give us a lead,” Middleton said. “That let us relax and play our own game.”Andre Drummond had 12 points and 12 rebounds, struggling with his own foul trouble. He missed eight of his first nine field-goal attempts.“I think Andre missed some bunnies and it bothered him,” Casey said. “He took that to the other end of the floor and missed some assignments on defense. He’s still learning how everything is magnified in the pressure of the playoffs.”Drummond picked up his fourth foul early in the third quarter, but Antetokounmpo left a minute later with his fourth.Middleton, playing against the team that drafted him in 2012, hit back-to-back 3-pointers to give Milwaukee an 85-66 lead with 4:47 left in the third quarter. Drummond returned late in the quarter, but picked up his fifth foul after just 41 seconds.“I thought they guys were amazing, especially after I got my fourth foul,” Antetokounmpo said. “Khris did a great job of guiding the team and making the right plays. It’s good to see us winning a playoff game on the road when I’m not having my best game.”Milwaukee Bucks forward Giannis Antetokounmpo (34) is defended by Detroit Pistons forward Blake Griffin during the first half of Game 3 of a first-round NBA basketball playoff series, Saturday, April 20, 2019, in Detroit. (AP Photo/Carlos Osorio)The margin was 100-78 at quarter’s end and the Pistons never put together a serious run in the fourth.“I think we definitely need some rest after Game 4, but we’re trying not to think about that,” Antetokounmpo said. “We’re going to come in, be hungry and try to win that game. It’s going to be a nice feeling — I’ve never won a playoff series.”TIP INSBucks: The Bucks hadn’t won the first three games of a playoff series since a three-game sweep of the New Jersey Nets in the 1986 first round. … Milwaukee was a plus-23 in the 10:48 that George Hill played in the first half.Pistons: The game was the first postseason game in Little Caesars Arena history. The Pistons and Red Wings both missed the playoffs in 2017-18 and the Red Wings missed again this season. The most recent NBA playoff game in the city of Detroit was April 27, 1985, when the Pistons lost 127-123 to the New York Knicks at Joe Louis Arena after damage to the Pontiac Silverdome’s roof.MATCHING AN UNPLEASANT MARKThe loss was Detroit’s 13th straight in the playoffs, tying the NBA record set by the New York Knicks between 2001-12. The Pistons lost the last two games of the 2008 Eastern Conference finals to the Boston Celtics, were swept by the Cleveland Cavaliers in the first round in 2009 and again in 2016 and have now lost three in a row to Milwaukee. Their last postseason win came over Boston on May 26, 2008.UP NEXTGame 4 is Monday night at Detroit.___By DAVE HOGG Associated PressTweetPinShare0 Shares
The Oklahoma State Cowboys racked up 555 total yards of offense and scored the most points since their season opener against the Texas Longhorns last Saturday. Receiver Jalen McCleskey led the Cowboys in receiving with four receptions for 109 yards and two touchdowns. Both touchdowns were on plays that the Cowboys have never run before. Today, we’re going to break them down.Mccleskey’s first score was on a vertical RPO off a quick snap. The Cowboys usually go quick snap following the first first down of a drive, and this was one of those plays that they used.In the play, Rudolph can either hand the ball off or throw to the slot receiver in the seam.The second time the Cowboys ran it, Rudolph handed it off to Justice Hill.But on the first time, the Cowboys caught the defense off-guard and McCleskey ran right past the secondary.The Cowboys have been excellent this season when it comes to tempo, and they have found success with the quick snap. The defense often doesn’t align quickly enough, and it allows the Cowboys to take advantage of the defense being out of place.McCleskey scored his second touchdown out of a formation that the Cowboys have never used before; it had the running back aligned off the line of scrimmage on the right and the tight end on the left with a slot receiver on the tight end side.The Cowboys showed the formation a couple of times before, but on the first time, Rudolph found his tight end Blake Jarwin off a chip release in the flat:On the second time they ran it, McCleskey found the soft spot in the zone and Rudolph threw the most accurate ball of the game for a score.This is a perfect example of how new schemes and concepts directly translate to success for an offense. Yurcich & Co. implemented these plays in this past week’s game plan, and the Longhorns, who have never seen these plays from the Cowboys before, couldn’t stop them. The Cowboy offensive coaching staff does an excellent job coming up with unique game plans every week. This one had a number of new plays, and players like McCleskey shined because of them.How would you rate the Cowboys’ game plan against the Longhorns? Leave your opinions below in the comments!If you’re looking for the comments section, it has moved to our forum, The Chamber. You can go there to comment and holler about these articles, specifically in these threads. You can register for a free account right here and will need one to comment.If you’re wondering why we decided to do this, we wrote about that here. Thank you and cheers!